|
|
Congress Alerts
|
Clinical Spotlight from the 2011 Annual Multidisciplinary Cancer Meeting in Stockholm
|
|
prIME Oncology invites you to view exciting news released from the 2011 Annual Multidisciplinary Cancer Meeting in Stockholm, Sweden
|
|
|
 |
|
27 September 2011
This expert interview with Eric Van Cutsem, MD, PhD, from the University Hospital Gasthuisberg,
Leuven, Belgium, and, Josep Tabernero, MD, from the Vall d'Hebron University Hospital, Barcelona, Spain, along with an eNewsflash and downloadable slides, covers the topic of metastatic colorectal cancer focusing on the following data release:
Abstract #LBA6: Results from VELOUR, a phase III study of aflibercept (A) versus placebo (pbo) in combination with FOLFIRI for the treatment of patients (pt) with previously treated metastatic colorectal cancer (MCRC)
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- Evaluate emerging clinical trial data pertaining to colorectal cancer and how this data should be incorporated into current standards of care to improve patient outcomes
- Discuss the rationale and utility of novel antiangiogenic agents that may provide superior outcomes for patients with colorectal cancer compared to current standards of care
View expert discussion and access the downloadable slides and eNewsflash
|
|
|
|
|
|
|
